| ChemoTHC | R Documentation |
THC for Antinausea Treatment in Chemotherapy
Description
Comparison of two treatments for nausea in chemotherapy
Format
A data frame with 2 observations on the following 4 variables.
Drug | Prochlorperazine or THC |
Effective | Count of effective cases |
NotEffective | Count of noneffective cases |
Patients | Number of patients in the treatment |
Details
An article in the New England Journal of Medicine described a study on the effectiveness of medications for combatting nausea in patients undergoing chemotherapy treatments for cancer. In the experiment, 157 patients were divided at random into two groups. One group of 78 patients was given a standard antinausea drug called prochlorperazine, while the other group of 79 patients received THC (the active ingredient in marijuana). Both medications were delivered orally and no patients were told which of the two drugs they were taking. The response measured was whether or not the patient experienced relief from nausea when undergoing chemotherapy. Dataset is a 2 x 2 table of counts.
Source
Sallan SE, Cronin C, Zelen M, Zinberg NE (1980), "Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine," New England Journal of Medicine, 302(3) p.135-138.